miRNA调控恶性黑色素瘤细胞上皮-间充质转化的分子网络及机制

doi:10.16288/j.yczz.15-022

遗传 ›› 2015, Vol. 37 ›› Issue (7): 673-682.doi: 10.16288/j.yczz.15-022

miRNA调控恶性黑色素瘤细胞上皮-间充质转化的分子网络及机制

王冬^{1, 4}, 李永君², 丁楠^{2, 3}, 王均云^{2, 3}, 杨琼^{2, 3}, 杨雅冉², 李艳明^{2, 3}, 方向东², 赵华¹

1. 中国人民解放军总医院皮肤科,北京 100853;
2. 中国科学院北京基因组研究所,中国科学院基因组科学与信息重点实验室,北京 100101;
3. 中国科学院大学,北京 100049;
4. 解放军第309医院,北京 100091

收稿日期:2015-01-18 修回日期:2015-04-01 出版日期:2015-07-20 发布日期:2015-07-20
通讯作者: 赵华,博士,主任医师,研究方向：皮肤肿瘤及变态反应性皮肤病。E-mail: luckhua301@163.com
作者简介:王冬,在读博士研究生,专业方向：恶性肿瘤的表观遗传学研究。Tel: 010-84097538;E-mail: wangdong@big.ac.cn;李永君,副研究员,专业方向：分子生物学。Tel: 010-84097538;E-mail: yjli@big.ac.cn。王冬和李永君为并列第一作者。
基金资助:
国家自然科学基金面上项目(编号：31471236)和国家高技术研究发展计划项目(863计划)(编号：2012AA022502)资助

Molecular networks and mechanisms of epithelial-mesenchymal transition regulated by miRNAs in the malignant melanoma cell line

Dong Wang^{1, 4}, Yongjun Li², Nan Ding^{2, 3}, Junyun Wang^{2, 3}, Qiong Yang^{2, 3}, Yaran Yang², Yanming Li^{2, 3}, Xiangdong Fang², Hua Zhao¹

1. Department of Dermatology, General Hospital of People's Liberation Army, Beijing 100853, China;
2. CAS Key Laboratory of Genome Sciences and Information, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China;
3. University of Chinese Academy of Sciences, Beijing 100049, China;
4. The 309th Hospital of China People’
s Liberation Army, Beijing 100091, China

Received:2015-01-18 Revised:2015-04-01 Online:2015-07-20 Published:2015-07-20

摘要/Abstract

摘要： 黑色素瘤是一种极易发生转移的恶性皮肤肿瘤,具有高度的致死性。上皮-间充质细胞转化(Epithelial-mesenchymal transition, EMT)在胚胎发育过程中起到非常重要的作用,同时在肿瘤的发生和恶化过程中也扮演着重要的角色。miRNA具有广谱的调节能力,对于肿瘤发生和EMT形成都能产生不同程度的影响。本文整合黑色素瘤细胞系转录组和miRNA组测序数据,在转录组数据中筛选得到参与肿瘤EMT过程的基因,通过Mirsystem软件预测并从miRNA组数据中筛选出与之负相关的11个miRNA,包括miR-130a-3p、miR-130b-3p、miR-125a-5p、miR-30a-3p、miR-195-5p、miR-345-5p、miR-509-3-5p、miR-374a-5p、miR-509-5p、miR-148a-3p和miR-330-3p。经过生物信息学分析miRNA靶基因富集的分子网络和信号途径,发现了两个与细胞发育和细胞间相互作用密切相关的网络,以及多个参与调控EMT过程的信号通路。对11个miRNA进行分子生物学验证,发现miR-195-5p、miR-130a-3p、miR-509-5p和miR-509-3-5p共4个可以调节重要肿瘤基因的miRNA。本研究运用mRNA和miRNA两种转录组的测序数据筛选EMT相关miRNA的方法,为肿瘤多组学数据整合分析提供了新的研究思路,并以期能为肿瘤精准基因组学的发展发挥重要的推进作用。

关键词: 黑素色瘤, 转录组, miRNA组, 上皮-间充质细胞转化

Abstract: Melanoma is a malignant cutaneous cancer of high metastasis and lethal rates. Epithelial-mesenchymal transition (EMT) plays an important role in the embryonic developmental process that is often activated during tumorigenesis and metastasis. In this study, we integrated of mRNA and miRNA transcriptome sequencing data of melanocyte and melanoma cell lines to identify genes involved in the process of tumor EMT in the first place, and uncovered 11 miRNAs including miR-130a-3p, miR-130b-3p, miR-125a-5p, miR-30a-3p, miR-195-5p, miR-345-5p, miR-509-3-5p, miR-374a-5p, miR-509-5p, miR-148a-3p and miR-330-3p, negatively related with EMT genes using the Mirsystem software. Bioinformatics analysis with target genes of these miRNAs revealed two networks closely related with cellular development and cell-to-cell interactions, as well as multiple signaling pathways participating in EMT. Validation of the 11 miRNAs with molecular biology experiments demonstrated that four miRNAs regulated oncogenes in melanomas, including miR-195-5p, miR-130a-3p, miR-509-5p, and miR-509-3-5p. Our study integrates two kinds of omics data to screen for EMT-related miRNAs, providing a new research idea in the precision genomics of cancer research.

Key words: melanoma, transcriptome, miRNAome, epithelial-mesenchymal transition

王冬, 李永君, 丁楠, 王均云, 杨琼, 杨雅冉, 李艳明, 方向东, 赵华. miRNA调控恶性黑色素瘤细胞上皮-间充质转化的分子网络及机制[J]. 遗传, 2015, 37(7): 673-682.

Dong Wang, Yongjun Li, Nan Ding, Junyun Wang, Qiong Yang, Yaran Yang, Yanming Li, Xiangdong Fang, Hua Zhao. Molecular networks and mechanisms of epithelial-mesenchymal transition regulated by miRNAs in the malignant melanoma cell line[J]. HEREDITAS(Beijing), 2015, 37(7): 673-682.

参考文献

[1] Pacheco I, Buzea C, Tron V. Towards new therapeutic approaches for malignant melanoma. Expert Rev Mol Med , 2011, 13: e33.
[2] Lujambio A, Lowe SW. The microcosmos of cancer. Nature , 2012, 482(7385): 347-355.
[3] Rigel DS, Russak J, Friedman R. The evolution of melanoma diagnosis: 25 years beyond the ABCDs. CA Cancer J Clin , 2010, 60(5): 301-316.
[4] Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol , 2014, 15(3): 178-196.
[5] Thiery JP, Acloque H, Huang RYJ, Nieto MA. Epithelial- mesenchymal transitions in development and disease. Cell , 2009, 139(5): 871-890.
[6] Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell , 2008, 14(6): 818-829.
[7] Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 . Cell , 1993, 75(5): 843-854.
[8] Mione M, Bosserhoff A. MicroRNAs in melanocyte and melanoma biology. Pigment Cell Melanoma Res , 2015, 28(3): 340-354.
[9] Dar AA, Majid S, Rittsteuer C, De Semir D, Bezrookove V, Tong S, Nosrati M, Sagebiel R, Miller JR, III, Kashani- Sabet M. The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression. J Natl Cancer Inst , 2013, 105(6): 433-442.
[10] Poenitzsch Strong AM, Setaluri V, Spiegelman VS. MicroRNA-340 as a modulator of RAS-RAF-MAPK signaling in melanoma. Arch Biochem Biophys , 2014, 563: 118-124.
[11] Aigner A. MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis- related miRNAs. J Mol Med , 2011, 89(5): 445-457.
[12] Sims D, Sudbery I, Ilott NE, Heger A, Ponting CP. Sequencing depth and coverage: key considerations in genomic analyses. Nat Rev Genet , 2014, 15(2): 121-132.
[13] Schneeberger K. Using next-generation sequencing to isolate mutant genes from forward genetic screens . Nat Rev Genet , 2014, 15(10): 662-676.
[14] Sarda S, Hannenhalli S. Next-generation sequencing and epigenomics research: a hammer in search of nails. Genomics Inform , 2014, 12(1): 2-11.
[15] Danielsson K, Mun LJ, Lordemann A, Mao J, Lin CHJ. Next-generation sequencing applied to rare diseases genomics. Expert Rev Mol Diagn , 2014, 14(4): 469-487.
[16] Zhao H, Li YJ, Wang SB, Yang YD, Wang JY, Ruan XY, Yang YR, Cai K, Zhang B, Cui P, Yan JW, Zhao YL, Wakeland EK, Li QZ, Hu SN, Fang XD. Whole transcriptome RNA-seq analysis: tumorigenesis and metastasis of melanoma. Gene , 2014, 548(2): 234-243.
[17] The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature , 2014, 511(7511): 543-550.
[18] The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature , 2014, 513(7517): 202-209.
[19] Ouyang M, Li YX, Ye S, Ma JY, Lu LM, Lv WM, Chang GQ, Li XX, Li Q, Wang SM, Wang WJ. MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer. PLoS One , 2014, 9(5): e96228.
[20] Mitra R, Edmonds MD, Sun JC, Zhao M, Yu H, Eischen CM, Zhao ZM. Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non- small cell lung cancer. RNA , 2014, 20(9): 1356-1368.
[21] Ben-Hamo R, Efroni S. MicroRNA-gene association as a prognostic biomarker in cancer exposes disease mechanisms. PLoS Comput Biol , 2013, 9(11): e1003351.
[22] Elgaaen BV, Olstad OK, Haug KBF, Brusletto B, Sandvik L, Staff AC, Gautvik KM, Davidson B. Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker. BMC Cancer , 2014, 14: 80.
[23] Hanahan D, Weinberg RA. The hallmarks of cancer. Cell , 2000, 100(1): 57-70.
[24] Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell , 2011, 144(5): 646-674.
[25] Sekulic A, Haluska P, Jr., Miller AJ, Genebriera De Lamo J, Ejadi S, Pulido JS, Salomao DR, Thorland EC, Vile RG, Swanson DL, Pockaj BA, Laman SD, Pittelkow MR, Markovic SN. Malignant melanoma in the 21st century: the emerging molecular landscape. Mayo Clin Proc , 2008, 83(7): 825-846.
[26] Pawlikowski JS, Mcbryan T, Van Tuyn J, Drotar ME, Hewitt RN, Maier AB, King A, Blyth K, Wu H, Adams PD. Wnt signaling potentiates nevogenesis. Proc Natl Acad Sci USA , 2013, 110(40): 16009-16014.
[27] Ni CS, Sun BC, Dong XY, Sun T, Zhao N, Liu YR, Gu Q. Promoting melanoma growth and metastasis by enhancing VEGF expression. Contemp Oncol (Pozn) , 2012, 16(6):526-531.
[28] Hodgson L, Henderson AJ, Dong C. Melanoma cell migration to type IV collagen requires activation of NF-κB. Oncogene , 2003, 22(1): 98-108.
[29] Muthusamy V, Piva TJ. The UV response of the skin: a review of the MAPK, NFκB and TNFα signal transduction pathways. Arch Dermatol Res , 2010, 302(1): 5-17.
[30] Clevers H, Nusse R. Wnt/β-catenin signaling and disease. Cell , 2012, 149(6): 1192-1205.
[31] Li VSW, Ng SS, Boersema PJ, Low TY, Karthaus WR, Gerlach JP, Mohammed S, Heck AJR, Maurice MM, Mahmoudi T, Clevers H. Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex. Cell , 2012, 149(6): 1245-1256.
[32] Lassen A, Atefi M, Robert L, Wong DJ, Cerniglia M, Comin-Anduix B, Ribas A. Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma. Mol Cancer , 2014, 13: 83.
[33] Box NF, Terzian T. The role of p53 in pigmentation, tanning and melanoma. Pigment Cell Melanoma Res , 2008, 21(5): 525-533.
[34] Lee B, Sandhu S, Mcarthur G. Cell cycle control as a promising target in melanoma. Curr Opin Oncol , 2015, 27(2): 141-150.
[35] Uzdensky AB, Demyanenko SV, Bibov MY. Signal transduction in human cutaneous melanoma and target drugs. Curr Cancer Drug Targets , 2013, 13(8): 843-866.
(责任编委: 宋旭)

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

miRNA调控恶性黑色素瘤细胞上皮-间充质转化的分子网络及机制

Molecular networks and mechanisms of epithelial-mesenchymal transition regulated by miRNAs in the malignant melanoma cell line

PDF (PC)

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	石田培,张莉. 全转录组学在畜牧业中的应用[J]. 遗传, 2019, 41(3): 193-205.
[2]	张高华, 于树涛, 王鹤, 王旭达. 高油酸花生发芽期低温胁迫转录组及差异表达基因分析[J]. 遗传, 2019, 41(11): 1050-1059.
[3]	任岚,肖茹丹,张倩,娄晓敏,张昭军,方向东. KLF1和KLF9对K562细胞红系分化的协同调控作用[J]. 遗传, 2018, 40(11): 998-1006.
[4]	杨莹,陈宇晟,孙宝发,杨运桂. RNA甲基化修饰调控和规律[J]. 遗传, 2018, 40(11): 964-976.
[5]	刘亚军,张峰,刘宏德,孙啸. 下一代测序技术在干细胞转录调控研究中的应用[J]. 遗传, 2017, 39(8): 717-725.
[6]	叶仲杰,刘启鹏,岑山,李晓宇. LINE-1编码的逆转录酶在肿瘤形成过程中的作用[J]. 遗传, 2017, 39(5): 368-376.
[7]	魏凯,马磊. 高通量测序时代下持家基因定义的发展[J]. 遗传, 2017, 39(2): 127-134.
[8]	李光奇, 孙从佼, 吴桂琴, 石凤英, 刘爱巧, 孙皓, 杨宁. 利用转录组测序筛选鸡蛋褐壳性状相关基因[J]. 遗传, 2017, 39(11): 1102-1111.
[9]	刘永明, 张玲, 邱涛, 赵卓凡, 曹墨菊. 高通量转录组测序技术在植物雄性不育研究中的应用[J]. 遗传, 2016, 38(8): 677-687.
[10]	朱帅旗, 龚一富, 杭雨晴, 刘浩, 王何瑜. 绿色杜氏藻转录组分析[J]. 遗传, 2015, 37(8): 828-836.
[11]	谢兵兵, 杨亚东, 丁楠, 方向东. 整合分析多组学数据筛选疾病靶点的精准医学策略[J]. 遗传, 2015, 37(7): 655-663.
[12]	江玮, 范一星, 乔贤, 张燕军, 刘志红, 赵艳红, 王瑞军, 王志新, 张文广, 苏蕊, 李金泉. 皮肤毛囊发育的转录组研究进展[J]. 遗传, 2015, 37(6): 528-534.
[13]	刘永明, 张玲, 周建瑜, 曹墨菊. 植物细胞核雄性不育相关bHLH转录因子研究进展[J]. 遗传, 2015, 37(12): 1194-1203.
[14]	刘欣,宋雪萤,张晓萍,韩英伦,朱婷,肖蓉,李庆伟. 七鳃鳗鳃黏膜免疫系统类淋巴细胞免疫应答遗传基础[J]. 遗传, 2015, 37(11): 1149-1159.
[15]	杨仙荣, 王美琴, 李少华. 人类Y染色体的演化[J]. 遗传, 2014, 36(9): 849-856.